Women's Software Firm Hits the Charts With Medical Device

By Michael S. Rosenwald
Washington Post Staff Writer
Thursday, March 22, 2007

The results of the Rockville Economic Development Inc. StartRight! Women's Business Plan Competition are in, and a small Rockville company that makes medical device software took home second place and $5,000.

Founded by Tia Gao and Cassedy Newgen, Aid Networks is designing software that would be used by medical devices to improve patient safety. The company's first product is a wireless system for hospitals that provides patient status updates to health-care providers.

First prize went to Kris Appel, the founder of Newregen, a Baltimore medical device company started last year to bring to market technology developed at the University of Maryland Baltimore County. Appel won $10,000.

Cheryl Staab of DogCentric in Rockville won third prize and $2,500. DogCentric provides dog-walking services to residents of Montgomery County and Northwest Washington.

Blending In at Balducci's

Mayorga Coffee Roasters, a minority-owned company based in Rockville, will soon be selling its specialty coffee at Balducci's in the District, Maryland and Virginia.

The coffee company, founded by Martin and Kerry Mayorga, uses high-grade specialty Arabica beans. At Balducci's, Mayorga will offer one-pound bags of Organic French Roast, Nicaragua La Bastilla Estate, Sumatra Mandheling, Mocha Java Estate and Panama Hartmann Estate.

"Balducci's entire concept centers on the freshest, finest specialty items available in the marketplace," said Martin Mayorga, president of Mayorga Coffee. "We are excited to be involved with such a distinguished brand."

Mayorga has six retail locations in the D.C. area.

Common Cause in Biotech

Here's a good-neighbor story: MedImmune of Gaithersburg is leasing a portion of a facility owned by Human Genome Sciences of Rockville.

MedImmune, the region's most successful biotech company and one of the biggest in the country, plans to use the leased facility for development of next-generation versions of seasonal and pandemic influenza vaccines.

"HGS and MedImmune work together in a number of ways to advance the interests of the biotechnology industry in Maryland and the Greater Washington region, and we are pleased to extend use of this state-of-the-art facility to MedImmune -- particularly for such an important national purpose," said Curran Simpson, HGS senior vice president of operations.

View all comments that have been posted about this article.

© 2007 The Washington Post Company